NCT07213609 2026-06-05A Study to Investigate the Safety and Preliminary Efficacy of GSK5460025 Alone or in Combination With Other Anti-cancer Agents in Participants With Solid TumorsGlaxoSmithKlinePhase 1/2 Recruiting47 enrolled